Synopsis
Cipla, a leading pharmaceutical company, reported a significant 49% increase in its Q3 FY25 net profit, reaching Rs 1,575 crore. Revenue also grew by 7% year-on-year, with strong performance in its Indian operations and new ventures segment.Key Takeaways
- 49% YoY rise in net profit to Rs 1,574.6 crore.
- 7% YoY revenue growth totaling Rs 7,073 crore.
- Indian operations revenue increased by 10% YoY.
- EBITDA grew by 15.7% YoY to Rs 1,989 crore.
- Strong performance in emerging markets and Europe.
Mumbai, Jan 28 (NationPress) The pharmaceutical giant Cipla announced a remarkable 49% year-on-year (YoY) increase in its consolidated net profit for the December quarter (Q3 FY25), reaching Rs 1,574.6 crore, up from Rs 1,068.5 crore in the same quarter last year (Q2 FY25).
The company’s revenue from operations saw a 7% YoY growth, totaling Rs 7,073 crore compared to Rs 6,604 crore in Q3 FY24, as reported in its exchange filing.
However, the revenue remained almost unchanged on a quarter-on-quarter (QoQ) basis, with figures at Rs 7,051 crore in Q2 FY25.
Revenue from Cipla’s Indian operations climbed by 10% YoY to Rs 3,146 crore, driven by strong performance in its branded prescription business, which outpaced market growth in significant therapies.
Cipla’s EBITDA for the quarter saw an increase of 15.7% YoY, reaching Rs 1,989 crore, with an enhanced EBITDA margin of 28.1%, up by 184 basis points.
The company attributed its sustained margins to improved operational efficiencies and a focused market strategy.
Notably, Cipla’s expenses for the quarter rose by 5% YoY to Rs 5,378 crore, although they were 1.3% lower QoQ.
The new ventures segment also performed admirably, generating Rs 341 crore in revenue for Q3 FY25, up from Rs 281 crore in Q3 FY24 and Rs 320 crore in the preceding quarter.
As per the filing, Cipla's growth was propelled by strong performances in emerging markets and Europe.
Additionally, the company observed that its trade generics segment is back on an upward growth trend, while its consumer health brands continue to thrive.
Following the announcement of these results, Cipla's stock closed higher by Rs 30.9, reaching Rs 1,427 per share.
